Astria Therapeutics Q3 EPS $(0.63) Vs $(0.87) Last Year
Portfolio Pulse from Benzinga Newsdesk
Astria Therapeutics (NASDAQ:ATXS) reported a narrower loss of $(0.63) per share in Q3 compared to $(0.87) per share in the same quarter last year, marking a 27.59% improvement.
November 13, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Astria Therapeutics reported a 27.59% year-over-year improvement in its quarterly EPS, with a loss of $(0.63) per share compared to $(0.87) last year.
The improvement in Astria Therapeutics' EPS indicates a positive development in the company's financial performance. This could lead to increased investor confidence and a potential short-term uptick in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100